Skip to main content
SpringerLink
Log in

The evaluation of the Turkish version of the Well-being Questionnaire (WBQ-22) in patients with Type 2 diabetes: The effects of diabetic complications

  • Original Articles
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Objective: Psychopathological conditions including depression and anxiety are important in patients with diabetes due to their negative effects on the quality of life, treatment and glycemic control. The specially designed questionnaire for diabetics, the Well-being Questionnaire (WBQ-22), was used to determine the psychological well-being in Turkish diabetic patients. Method: A total of 100 patients, 45 males and 55 females, were included in the study. Patients completed WBQ-22 questionnaire. Results: Sex, in-patient follow-up, age, duration of diabetes, form of treatment, diabetic microvascular complications, diabetic foot, and increased number of complications were the factors detected to have an effect on the scores of general well-being or its subscales. Scores of depression and general well-being were 7.10±3.82 and 39.74±12.27 in females, and 4.20±3.48 and 48.84±11.45 in males (p<0.05). Anxiety score was found to be 5.70±3.71 in the outpatient clinic, and 7.28±4.38 in the inpatient clinics (p<0.05). General well-being score was 49.40±8.83 in patients having a diabetes duration of 1 yr or less and 33.70±8.83 in patients with 20 yr or more (p<0.05). Patients treated with insulin had depression score of 7.02±4.07 whereas patients treated with diet had 4.50±3.27 (p<0.05). The increasing total chronic complication points were also found to have a negative effect on WBQ-22 scores. General well-being score was 51.08±9.84 in patients with no complications and 34.50±14.14 in patients with 4 complications (p<0.05). Conclusions: Psychosocial support should be provided to Type 2 diabetic patients by studying the psychological well-being with WBQ-22 questionnaire.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Constitution of the World Health Organization. In: Handbook of Basic Documents, World Health Organization, 5th ed. Geneva: Palais des Nations. 1952, 3–20.

  2. Rubin RR, Peyrot M. Quality of life and diabetes. Diabetes Metab Res Rev 1999, 15: 205–18.

    Article  PubMed  CAS  Google Scholar 

  3. World Health Organization (Europe) and International Diabetes Federation (Europe). Diabetes care and research in Europe: the Saint Vincent Declaration. Diabet Med 1990, 7: 360.

    Article  Google Scholar 

  4. Satman I, Yilmaz T, Sengul A, et al. Population-based study of diabetes and risk characteristics in Turkey: results of the turkish diabetes epidemiology study (TURDEP). Diabetes Care 2002, 25: 1551–6.

    Article  PubMed  Google Scholar 

  5. Satman I, Yilmaz T, Bastar I, et al. Diabetes epidemiology study in Turkey: first step data results (A384). Diabetes 1998, 47: 1480.

    Article  Google Scholar 

  6. Rubin RR, Peyrot M. Psychosocial problems and interventions in diabetes. A review of the literature. Diabetes Care 1992, 15: 1640–57.

    Article  PubMed  CAS  Google Scholar 

  7. Rose M, Fliege H, Hildebrandt M, Schirop T, Klapp BF. The network of psychological variables in patients with diabetes and their importance for quality of life and metabolic control. Diabetes Care 2002, 25: 35–42.

    Article  PubMed  Google Scholar 

  8. Skinner TC. Psychological barriers. Eur J Endocrinol 2004, 151(Suppl 2): T13–7.

    Article  PubMed  CAS  Google Scholar 

  9. Gavard JA, Lustman PJ, Clouse RE. Prevalance of depression in adults with diabetes. An epidemiological evaluation. Diabetes Care 1993, 16: 1167–78.

    Article  PubMed  CAS  Google Scholar 

  10. Peyrot M, Rubin RR. Levelsand risks of depression and anxiety symptomatology among diabetic adults. Diabetes Care 1997, 20: 585–90.

    Article  PubMed  CAS  Google Scholar 

  11. Lustman PJ, Griffith LS, Freedland KE, et al. Cognitive behavior therapy for depression in type 2 diabetes mellitus. A randomized, controlled trial. Ann Intern Med 1998, 129: 613–21.

    Article  PubMed  CAS  Google Scholar 

  12. Littlefield CH, Craven JL, Rodin GM, et al. Relationship of self-efficacy and binging to adherence to diabetes regimen among adolescents. Diabetes Care 1992; 15: 90–4.

    Article  PubMed  CAS  Google Scholar 

  13. Lustman PJ, Griffith LS, Clouse RE. Depression in adults with diabetes. Results of 5-yr follow-up study. Diabetes Care 1988, 11: 605–12.

    Article  PubMed  CAS  Google Scholar 

  14. de Groot M, Jacobson AM, Samson JA. Psychiatric illness in patients with type I and type II diabetes mellitus. Psychosom Med 1994, 56: A176.

    Google Scholar 

  15. Van der Does FE, De Neeling JN, Snoek FJ, et al. Symptoms and well-being in relation to glycemic control in type II diabetes. Diabetes Care 1996, 19: 204–10.

    Article  PubMed  Google Scholar 

  16. Carney RM, Rich MW, Freedland KE, et al. Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med 1988, 50: 627–33.

    PubMed  CAS  Google Scholar 

  17. Bradley C. The well-being questionnaire. In: Handbook of Psychology and Diabetes: a guide to psychological measurement in diabetes research and practice. Bradley C ed. Amsterdam: The Netherlands: Harwood Academic Publishers. 1994: 89–109.

    Google Scholar 

  18. Gaede P, Vedel P, Parving HH, Pedersen O. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet 1999, 353: 617–22.

    Article  PubMed  CAS  Google Scholar 

  19. Aiello LM. Perspectives on diabetic retinopathy. Am J Ophthalmol 2003, 136: 122–35.

    Article  PubMed  Google Scholar 

  20. Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998, 97: 1837–47.

    Article  PubMed  CAS  Google Scholar 

  21. Lustman PJ, Harper GW. Nonpsychiatric physicians’ identification and treatment of depression in patients with diabetes. Compr Psychiatry 1987, 28: 22–7.

    Article  PubMed  CAS  Google Scholar 

  22. Bradley C, Lewis KS. Measures of psychological well-being and treatment satisfaction developed from the responses of people with tablet-treated diabetes. Diabet Med 1990, 7: 445–51.

    Article  PubMed  CAS  Google Scholar 

  23. Petterson T, Lee P, Hollis S, et al. Well-being and treatment satisfaction in older people with diabetes. Diabetes Care 1998, 21: 930–5.

    Article  PubMed  CAS  Google Scholar 

  24. Glasgow RE, Ruggiero L, Eakin EG, et al. Quality of life and associated characteristics in a large national sample of adults with diabetes. Diabetes Care 1997, 20: 562–7.

    Article  PubMed  CAS  Google Scholar 

  25. Hezer O, Sargin M, Sengul A, et al. The effects of hypertension on general well-being in type 2 diabetes [Poster in Turkish]. 37th National Diabetes Congress 2001: PS 9/80.

  26. Gedik S, Sengul A, Salman F, et al. Marked determinants of well-being of patients with type 2 diabetes in Turkey. Diabetologia 2000, 43(Suppl 1): A 224.

    Google Scholar 

  27. Topsever P, Salman S, Aydın N, et al. Patient education: a crucial factor in well-being of type 2 diabetic patients. Diabetologia 2000, 43(Suppl 1): A 220.

    Google Scholar 

  28. Pouwer F, van der Ploeg HM, Ader HJ, et al. The 12-item well-being questionnaire. An evaluation of its validity and reliability in Dutch people with diabetes. Diabetes Care 1999, 22: 2004–10.

    Article  PubMed  CAS  Google Scholar 

  29. Ozer E, Sengul AM, Gedik S, et al. Diabetes education: a chance to improve well-being of Turkish people with type 2 diabetes. Patient Educ Couns 2003, 51: 39–44.

    Article  PubMed  Google Scholar 

  30. Kessler RC, McGonagle KA, Swartz M, et al. Sex and depression in the National Comorbidity Survey. I: Lifetime prevalance, chronicity, and recurrence. J Affect Disord 1993, 29: 85–96.

    Article  PubMed  CAS  Google Scholar 

  31. Gedik S, Sengul A, Salman S, et al.The relationship between hospitalization and well-being in type 2 diabetes [Poster in Turkish]. 37th National Diabetes Congress 2001: PS 9/81.

  32. Fisher L, Chesla CA, Mullan JT, et al. Contributors to depression in Latino and European-American patients with type 2 diabetes. Diabetes Care 2001, 24: 1751–7.

    Article  PubMed  CAS  Google Scholar 

  33. Atiea JA, Moses JL, Sinclair AJ. Neuropsychological function in older subjects with non-insulin-dependent diabetes mellitus. Diabet Med 1995, 12: 679–85.

    Article  PubMed  CAS  Google Scholar 

  34. Perlmuter LC, Hakami MK, Hodgson-Harrington C, et al. Decreased cognitive function in aging non-insulin-dependent diabetic patients. Am J Med 1984; 77: 1043–8.

    Article  PubMed  CAS  Google Scholar 

  35. Knopman D, Boland LL, Mosley T, et al. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 2001, 56: 42–8.

    Article  PubMed  CAS  Google Scholar 

  36. Fontbonne A, Berr C, Ducimetiere P, Alperovitch A. Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study. Diabetes Care 2001, 24: 366–70.

    Article  PubMed  CAS  Google Scholar 

  37. Logroscino G, Kang JH, Grodstein F. Prospective study of type 2 diabetes and cognitive decline in women aged 70–81 years. BMJ 2004, 328: 548.

    Article  PubMed Central  PubMed  Google Scholar 

  38. Asimakopoulou KG, Hampson SE, Morrish NJ. Neuropsychological functioning in older people with type 2 diabetes: the effect of controlling for confounding factors. Diabet Med 2002, 19: 311–6.

    Article  PubMed  CAS  Google Scholar 

  39. Jacobson AM, de Groot M, Samson JA. The evaluation of two measures of quality of life in patients with type I and II diabetes. Diabetes Care 1994, 17: 267–74.

    Article  PubMed  CAS  Google Scholar 

  40. Bradley C. Diabetes treatment satisfaction questionnaire (DTSQ). In: Handbook of Psychology and Diabetes: a guide to psychological measurement in diabetes research and practice. Bradley C ed. Amsterdam, The Netherlands: Harwood Academic Publishers. 1994: 111–32.

    Google Scholar 

  41. Reza M, Taylor CD, Towse K, Ward JD, Hendra TJ. Insulin improves well-being for selected elderly type 2 diabetic subjects. Diabetes Res Clin Pract 2002, 55: 201–17.

    Article  PubMed  CAS  Google Scholar 

  42. Sevinc A, Savli H, Serbest S, Harputluoglu M. The clinical evaluation of diabetic patients between 1996 and 1998 in Inonu University School of Medicine, Turgut Ozal Medical Center [Article in Turkish]. Turgut Ozal Tip Merk Derg 1999, 6: 213–7.

    Google Scholar 

  43. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993, 329: 977–86.

    Article  Google Scholar 

  44. Anderson RM, Fitzgerald JT, Wisdom K, et al. A comparison of global versus disease-specific quality-of-life measures in patients with NIDDM. Diabetes Care 1997, 20: 299–305.

    Article  PubMed  CAS  Google Scholar 

  45. Hanestad BR, Hornquist JO, Albrektsen G. Self-assessed quality of life and metabolic control in persons with insulin-dependent diabetes mellitus (IDDM). Scand J Soc Med 1991, 19: 57–65.

    PubMed  CAS  Google Scholar 

  46. The Diabetes Control and Complications Trial Research Group. Influence of intensive diabetes treatment on quality-of-life outcomes in the diabetes control and complications trial. Diabetes Care 1996, 19: 195–203.

    Article  Google Scholar 

  47. Wredling R, Stalhammar J, Adamson U, et al. Well-being and treatment satisfaction in adults with diabetes: a Swedish population-based study. Qual life Res 1995, 4: 515–22.

    Article  PubMed  CAS  Google Scholar 

  48. Hekimoglu S, Sengul A, Selimoglu O, et al. Type 2 diabetes: Is it the main factor effecting well-being in obese patients? [Poster in Turkish] 37th National Diabetes Congress 2001: PS 9/76.

  49. Van Tilburg MA, McCaskill CC, Lane JD, et al. Depressed mood is a factor in glycemic control in type 1 diabetes. Psychosom Med 2001, 63: 551–5.

    PubMed  Google Scholar 

  50. Lustman PJ, Anderson RJ, Freedland KE, et al. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 2000, 23: 934–42.

    Article  PubMed  CAS  Google Scholar 

  51. Sacco WP. Invalid use of the Beck Depression Inventory to identify depressed college-student subjects: a methodological comment. Cognitive Ther Res 1981, 5: 143–7.

    Article  Google Scholar 

  52. Turkington RW. Depression masquerading as diabetic neuropathy. JAMA 1980, 243: 1147–50.

    Article  PubMed  CAS  Google Scholar 

  53. Karlson B, Agardh CD. Burden of illness, metabolic control, and complications in relation to depressive symptoms in IDDM patients. Diabet Med 1997, 14: 1066–72.

    Article  PubMed  CAS  Google Scholar 

  54. de Groot M, Anderson R, Freedland KE, et al. Association of depression and diabetes complications: a meta-analysis. Psychosom Med 2001, 63: 619–30.

    PubMed  Google Scholar 

  55. Carney RM, Freedland KE, Lustman PJ, et al. Depression and coronary disease in diabetic patients: a 10-yearfollow-up. Psychosom Med 1994, 56: A149.

    Google Scholar 

  56. Cohen ST, Welch G, Jacobson AM, et al. The association of lifetime psychiatric illness and increased retinopathy in patients with type I diabetes mellitus. Psychosomatics 1997, 38: 98–108.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Haydarpasa Numune Training and Research Hospital, Istanbul

    H. Savli MD

  2. Department of Internal Medicine, Sahinbey Medical Center, Gaziantep University, School of Medicine, Gaziantep, TR-27310, Turkey

    A. Sevinc

Authors
  1. H. Savli MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Sevinc
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H. Savli MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Savli, H., Sevinc, A. The evaluation of the Turkish version of the Well-being Questionnaire (WBQ-22) in patients with Type 2 diabetes: The effects of diabetic complications. J Endocrinol Invest 28, 683–691 (2005). https://doi.org/10.1007/BF03347550

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03347550

Keywords

Search

Navigation